These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 2419277

  • 1. Treatment of experimental allergic encephalomyelitis in rabbits with alpha-fetoprotein.
    Brenner T, Evron S, Soffer D, Abramsky O.
    Isr J Med Sci; 1985 Dec; 21(12):945-9. PubMed ID: 2419277
    [Abstract] [Full Text] [Related]

  • 2. [Assay of myelin basic protein (MBP) antibody in the cerebrospinal fluid and serum of rabbits with experimental allergic encephalomyelitis (EAE) before and after sensitization].
    Gao Y.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):165-7, 190-1. PubMed ID: 1697235
    [Abstract] [Full Text] [Related]

  • 3. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS, Huston K, Shaw M, Tse HY, Raine CS.
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [Abstract] [Full Text] [Related]

  • 4. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.
    Irony-Tur-Sinai M, Grigoriadis N, Lourbopoulos A, Pinto-Maaravi F, Abramsky O, Brenner T.
    Exp Neurol; 2006 Mar; 198(1):136-44. PubMed ID: 16423348
    [Abstract] [Full Text] [Related]

  • 5. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.
    Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, McFarlin DE, Scott DE.
    J Immunol; 1995 Jan 01; 154(1):450-8. PubMed ID: 7527821
    [Abstract] [Full Text] [Related]

  • 6. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY, Yang JS, Huang YM, Levi M, Link H, Xiao BG.
    Clin Immunol; 2000 Sep 01; 96(3):205-11. PubMed ID: 10964538
    [Abstract] [Full Text] [Related]

  • 7. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
    Ramírez F, Mason D.
    Eur J Immunol; 2000 Mar 01; 30(3):747-58. PubMed ID: 10741389
    [Abstract] [Full Text] [Related]

  • 8. Antibodies which block anti-myelin basic protein antibodies associated with development of experimental autoimmune encephalomyelitis in Wistar rats.
    Vilcaes AA, Degano AL, López PH, Nores GA, Roth GA.
    J Neuroimmunol; 2005 Jul 01; 164(1-2):31-6. PubMed ID: 15950291
    [Abstract] [Full Text] [Related]

  • 9. Passive transfer of experimental allergic encephalomyelitis by myelin basic protein-specific L3T4+ T cell clones possessing several functions.
    Lemire JM, Weigle WO.
    J Immunol; 1986 Nov 15; 137(10):3169-74. PubMed ID: 2430015
    [Abstract] [Full Text] [Related]

  • 10. Diversity of the B cell repertoire to myelin basic protein in rat strains susceptible and resistant to EAE.
    Figueiredo AC, Cohen IR, Mor F.
    J Autoimmun; 1999 Feb 15; 12(1):13-25. PubMed ID: 10028018
    [Abstract] [Full Text] [Related]

  • 11. [Humoral autoimmune responses to neurospecific proteins in rats with experimental allergic encephalomyelitis and immunomodulation with allogeneic nervous tissue].
    Lisianyĭ MI, Liubych LD, Markova OV, Biel's'ka LM.
    Fiziol Zh (1994); 2002 Feb 15; 48(1):15-24. PubMed ID: 11928626
    [Abstract] [Full Text] [Related]

  • 12. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes.
    Samson MF, Smilek DE.
    J Immunol; 1995 Sep 01; 155(5):2737-46. PubMed ID: 7544383
    [Abstract] [Full Text] [Related]

  • 13. Influence of tetramisole on the induction of experimental allergic encephalomyelitis (EAE).
    Todorov DM, Michailov WG, Drumtcheva MA.
    Allerg Immunol (Leipz); 1982 Sep 01; 28(3):192-6. PubMed ID: 6183965
    [Abstract] [Full Text] [Related]

  • 14. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, Roig P, De Nicola AF.
    Neuroimmunomodulation; 2008 Sep 01; 15(1):76-83. PubMed ID: 18667803
    [Abstract] [Full Text] [Related]

  • 15. Experimental allergic encephalomyelitis in the chicken. Class-specific antibody to myelin basic protein, the ability of T cells to cause GvH reaction, brain and spleen histology, and nonspecific biochemical indicators of inflammation.
    Błaszczyk B, Viljanen MK, Molnar G, Giełodanowski J, Katkiewicz M, Hraba T, Krawczyk E.
    Arch Immunol Ther Exp (Warsz); 1984 Sep 01; 32(6):703-9. PubMed ID: 6085612
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
    Hilliard BA, Kamoun M, Ventura E, Rostami A.
    Exp Mol Pathol; 2000 Feb 01; 68(1):29-37. PubMed ID: 10640452
    [Abstract] [Full Text] [Related]

  • 17. Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity.
    Willenborg DO, Staykova MA, Miyasaka M.
    J Immunol; 1996 Sep 01; 157(5):1973-80. PubMed ID: 8757317
    [Abstract] [Full Text] [Related]

  • 18. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein.
    Fritz RB, Chou CH, McFarlin DE.
    J Immunol; 1983 Mar 01; 130(3):1024-6. PubMed ID: 6185565
    [Abstract] [Full Text] [Related]

  • 19. Experimental allergic encephalomyelitis: suppression with SD-170, a new synthetic drug.
    Kasckow JW, Tabira T, Itoyama Y, Kuroiwa Y, Takenaka A, Nagai Y.
    Jpn J Exp Med; 1981 Oct 01; 51(5):293-8. PubMed ID: 6172610
    [Abstract] [Full Text] [Related]

  • 20. Molecular and cellular determinants of neuroimmunologic inflammatory disease.
    Paterson PY.
    Fed Proc; 1982 Jul 01; 41(9):2569-76. PubMed ID: 6177557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.